

Transforming the Treatment of Kidney Disease
Walden Biosciences is a completely different type of biotech company. Our science is changing the treatment of kidney disease for patients.

PIPELINE
Walden is advancing a pipeline of novel, disease-modifying therapies that directly target the kidney.

PATIENTS
At Walden, we are committed to developing promising new therapies for people living with kidney disease.

PRESS RELEASES
Walden Biosciences Appoints Howard Mayer, M.D. to Board of Directors
January 28, 2025
Walden Biosciences Highlights 2024 Accomplishments and 2025 Priorities
January 10, 2025